U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...
Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) ...
Sickle cell patients say they struggle to receive appropriate care, especially in emergency room settings. Overcoming some of ...
Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...
Prime Cabinet Secretary Musalia Mudavadi states that the government of Kenya has intensified efforts to tackle the challenge ...
September is National Sickle Cell Awareness Month and Carillion Clinic Sickle Cell Collaborative is holding an awareness walk ...
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
Gene therapy for sickle cell disease remains a tough business model — and may never work, @adamfeuerstein writes.